COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,536 Articles (22,881 medRxiv, 8,655 bioRxiv)

Most recent first Previous |  Page 206: Articles 2051-2060  | Next

Torsional Twist of the SARS-CoV and SARS-CoV-2 SUD-N and SUD-M domains
Rosas-Lemus, M., Minasov, G., Brunzelle, J. S., Taha, T. Y., Lemak, S., Yin, S., Shuvalova, L., Rosecrans, J., Khanna, K., Seifert, H. S., Savchenko, A., Stogios, P. J., Ott, M., Satchell, K. J.
10.1101/2024.08.13.607777 — Posted: 2024-08-14
How does policy modelling work in practice? A global analysis on the use of modelling in Covid-19 decision-making
Hadley, L., Rich, C., Tasker, A., Restif, O., Funk, S.
10.1101/2024.08.12.24311899 — Posted: 2024-08-13
Effectiveness of XBB.1.5 monovalent COVID-19 vaccine against COVID-19 mortality in Australians aged 65 years and older during August 2023 to February 2024
Liu, B., Scaria, A., Stepien, S., Macartney, K.
10.1101/2024.08.12.24311895 — Posted: 2024-08-13
Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages
Wang, Q., Guo, Y., Ho, J., Ho, D. D.
10.1101/2024.08.12.607496 — Posted: 2024-08-13
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Franchini, M., Casadevall, A., Dragotakes, Q., Focosi, D.
10.1101/2024.08.12.24311864 — Posted: 2024-08-12
Analysis of a Stochastic COVID-19 and Hepatitis B Coinfection Model with Brownian and Levy Noise
POBBI, M. A., MOORE, S. E., NAANDAM, S. M.
10.1101/2024.08.12.24311861 — Posted: 2024-08-12
Simplified and Rapid Workflow Enhances Throughput of De Novo Sequencing of COVID-19 Neutralizing Antibodies
Xiong, Y., Xiao, J., Jiang, W., Wang, J., Bu, Q., Chen, X., Wu, Y., Yu, R., Yuan, Q., Xia, N.
10.1101/2024.08.09.607349 — Posted: 2024-08-12
ESPClust: Unsupervised identification of modifiers for the effect size profile in omics association studies
Perez-Reche, F. J., Cheetham, N., Bowyer, R., Thompson, E. J., Tettamanzi, F., Menni, C., Steves, C.
10.1101/2024.08.11.607486 — Posted: 2024-08-12
Genome-wide association study of COVID-19 Breakthrough Infections and genetic overlap with other diseases: A study of the UK Biobank
FENG, Y., Wong, K. C. Y., TSUI, W. K., ZHANG, R., XIANG, Y., So, H.-C.
10.1101/2024.08.11.24311845 — Posted: 2024-08-12
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Whittaker, C., Barnsley, G., Olivera Mesa, D., Laydon, D. J., Tan, C. W., Zhu, F., Johnson, R., Doohan, P., Nedjati-Gilani, G., Winskill, P., Hogan, A., Deol, A., Mukandavire, C., Hauck, K., Lye, D. C. B., Wang, L.-F., Watson, O. J., Ghani, A.
10.1101/2024.08.12.24311730 — Posted: 2024-08-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).